博济医药控股股东及其一致行动人减持116.1万股，权益变动触及1%

Core Viewpoint - Boji Pharmaceutical Technology Co., Ltd. disclosed the progress of share reduction by its controlling shareholder and related parties, indicating a decrease in their shareholding that has reached a 1% threshold [1][3]. Summary by Sections Reduction Plan Review - On August 22, 2025, Boji Pharmaceutical announced a share reduction plan involving its controlling shareholder Wang Tingchun and his concerted party, the Hengqin Guangjin Meihao Fund Management Co., Ltd. - Guangjin Meihao Fermi No. 13 Private Securities Investment Fund, intending to reduce up to 11,486,500 shares (3.00% of the total share capital excluding repurchased shares) within three months from September 12 to December 11, 2025 [2]. Reduction Progress - From September 12 to October 17, 2025, Fermi No. 13 reduced its holdings by 1,161,000 shares, representing 0.30% of the total share capital [3]. - Due to the exercise of stock options from the 2022 incentive plan, the total share capital increased, leading to a passive reduction of 0.02% in the shareholding percentage of Wang Tingchun, Fermi No. 13, and Zhao Lingli [3]. - The total shareholding of Wang Tingchun and his concerted parties decreased from 143,430,690 shares to 142,269,690 shares, reducing their ownership percentage from 37.20% to 36.88% [3]. Shareholding Structure Before and After - Before the reduction: - Wang Tingchun held 118,674,370 shares (30.78% of total share capital) - Fermi No. 13 held 5,536,700 shares (1.44%) - Zhao Lingli held 19,219,620 shares (4.98%) - Total: 143,430,690 shares (37.20%) - After the reduction: - Wang Tingchun held 118,674,370 shares (30.77%) - Fermi No. 13 held 4,375,700 shares (1.13%) - Zhao Lingli remained at 19,219,620 shares (4.98%) - Total: 142,269,690 shares (36.88%) [4]. Compliance and Impact of Reduction - The reduction plan complies with relevant laws and regulations, and it will not lead to a change in control of the company or significantly impact its ongoing operations [4]. - The company will continue to monitor the situation and fulfill its information disclosure obligations [4].